Condition
    Preliminary
    Effectiveness 2/5

    Vitamin D for Chronic Urticaria

    Vitamin D as an add-on to antihistamines produced modest symptom improvement in small chronic urticaria trials. It is an adjunct, not a treatment.

    Overview

    Vitamin D as an add-on to antihistamines produced modest symptom improvement in small chronic urticaria trials. It is an adjunct, not a treatment.

    Verdict

    Mixed evidence

    Reasonable to test and correct vitamin D if you have chronic urticaria, but keep the antihistamine as the mainstay.

    How It Works

    Vitamin D modulates T-regulatory cell function and mast cell stability, and low levels are associated with heightened allergic and autoimmune activity. In chronic spontaneous urticaria, which is frequently autoimmune, this offers a plausible route to reduced mast cell degranulation.

    Dosing & Protocol

    Typical dose

    Recommended dose
    4000 IU daily as an adjunct where levels are low or borderline, with retesting at three months
    Expected timeframe
    Symptom score changes emerged around 6-12 weeks in trials

    Protocol

    form
    Vitamin D3 (cholecalciferol)
    duration
    12 weeks with an urticaria activity score at baseline and end
    co factor
    Take with the largest meal and continue guideline antihistamine treatment. Evidence is preliminary: a randomised add-on trial found 4000 IU/day improved urticaria severity scores more than a low-dose comparator over 12 weeks, and observational work links low vitamin D to chronic urticaria, but the trial base is small and replication is limited.
    titration
    Check 25-hydroxyvitamin D and target 75-125 nmol/L. One randomised trial used a high add-on dose of 4000 IU/day for 12 weeks under supervision
    starting dose
    1000-2000 IU (25-50 mcg) vitamin D3 daily with a fat-containing meal, alongside - never instead of - antihistamines

    Evidence

    What the studies say

    A randomised trial of add-on vitamin D3 4000 IU versus 600 IU daily alongside standard triple-drug therapy found a significantly greater reduction in urticaria symptom scores in the high-dose group by week 12. Several observational studies report lower 25-OH-D in chronic urticaria patients than controls. Trials are small, short and single-centre, and no study shows benefit as monotherapy. Rating reflects plausible mechanism and consistent but low-powered clinical data.

    Effects of Serum Vitamin D Levels and Vitamin D Supplementation on Urticaria: A Systematic Review and Meta-Analysis

    Score: 7/10
    2021
    meta_analysis

    Li Y, Cao Z, Guo J +2 more

    Six VitD supplementation trials showed a significant reduction in clinical urticarial score on intervention with VitD.

    View source

    Efficacy and safety of active vitamin D supplementation in chronic spontaneous urticaria patients

    Score: 6/10
    2022
    rct
    n=77

    Mohamed AA, Hussein MS, Salah EM +5 more

    After alfacalcidol administration, the study group showed significant higher level of 25(OH) D compared to the placebo group. In addition, the mean serum level of IL6, hsCRP and TNFα significantly decreased.

    View source

    Chronic urticaria merits serum vitamin D evaluation and supplementation; a randomized case control study

    Score: 5/10
    2015
    rct
    n=192

    Rasool R, Masoodi KZ, Shera IA +5 more

    Vit-D3 supplementation in combination with antihistamine and systemic corticosteroid show elevated response in resolving the symptoms of CU.

    View source

    Chronic urticaria and vitamin D supplementations: a systematic review

    Score: 6/10
    2025
    systematic_review
    n=1491

    Siddiqui A, Bai A, Kumar H +6 more

    High-dose regimens (e.g., 4,000 IU/day or 60,000 IU/week) appeared more effective.

    View source

    The effect of vitamin D add-on therapy on the improvement of quality of life and clinical symptoms of patients with chronic spontaneous urticaria

    Score: 6/10
    2023
    rct
    n=80

    Nabavizadeh SH, Alyasin S, Esmaeilzadeh H +2 more

    Quality of life score was also significantly reduced; decrement in group 2 score was significant compared to group 1 at both weeks 6 (P = 0.005) and 12 (P = 0.007).

    View source

    Beneficial role for supplemental vitamin D3 treatment in chronic urticaria: a randomized study

    Score: 7/10
    2014
    rct
    n=42

    Rorie A, Goldner WS, Lyden E +1 more

    Triple-drug therapy decreased total USS scores by 33% in the first week. There was a further significant decrease (40%) in total USS scores in the high, but not low, vitamin D3 treatment group by week 12.

    View source

    Safety

    Caveats

    Does not replace antihistamines. Avoid sustained doses above 4000 IU daily without monitoring calcium and 25-OH-D. No effect on acute urticaria or anaphylaxis.

    Less likely to help if

    People with normal vitamin D and physically induced urticaria showed the least response.

    Medical Disclaimer

    The information provided on this website is for educational and informational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition or before starting any supplement regimen.

    Individual results may vary. The statements on this website have not been evaluated by the Food and Drug Administration. Products and information are not intended to diagnose, treat, cure, or prevent any disease.